Patents for C12R 1 - Micro-organisms (92,025)
11/2003
11/27/2003WO2003097849A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003WO2003097844A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/27/2003WO2003097815A2 Molecular identification of aspergillus species
11/27/2003WO2003097091A2 Glucan-based vaccines
11/27/2003WO2003032718A3 Anaerobic ammonium oxidation for water treatment in recirculating aquaculture
11/27/2003WO2002072856A3 Improved process for converting nitriles to carboxylic acids using nitrilase
11/27/2003WO2002064624A8 Improved method for production of secreted proteins in fungi
11/27/2003WO2002061109A3 Yeast strains autonomously producing steroids
11/27/2003US20030221209 Modified proteinase inhibitors
11/27/2003US20030220484 Modified ciliary neurotrophic factors
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220472 Treatment of hematopoietic cell deficiencies, stimulating the production of hematopoietic cells, recombinant DNA sequence encodes or vector expression of the muteins; side effect reduction
11/27/2003US20030220405 DNA encoding an epsilon, epsilon-lycopene cyclase from romaine lettuce
11/27/2003US20030220379 Fermentative preparation process for and crystal forms of cytostatics
11/27/2003US20030219900 Method and marker for simple transformation and selection of recombinant protists
11/27/2003US20030219882 Isolating glutamic acid from genetically engineered enterobacter culture for use in animal feeds, cosmetics and food processing
11/27/2003US20030219876 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/27/2003US20030219873 Self-assembling recombinant papillomavirus capsid proteins
11/27/2003US20030219870 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof
11/27/2003US20030219855 Comprises genetically engineered transcription factor for identifying elements associated neuronal differentiation/determination
11/27/2003US20030219735 Genetically engineered adeno-associated viral vector comprising single stranded heterologous nucleotide sequence for use as tool diagnostic tool in gene therapy and genomic screening
11/27/2003US20030219512 Bacterial extracellular polysaccharide, gluconacetobacter spp. strain producing it and their use in food or pet food products
11/27/2003US20030219443 Mycobacterium tuberculosis superoxide dismutase
11/27/2003US20030219437 Administering antibodies used as antagonists to CD antigen ligands on the cells, for prophylaxis of cardiovascular, gastrointestinal or urogenital disorders
11/27/2003CA2830619A1 Glucan-based vaccines
11/27/2003CA2486483A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003CA2485847A1 Glucan-based vaccines
11/27/2003CA2484744A1 Molecular identification of aspergillus species
11/27/2003CA2481783A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/26/2003EP1364969A2 Human tissue factor related DNA segments, polypeptides and antibodies
11/26/2003EP1364586A1 Probiotics and oral tolerance
11/26/2003EP1364041A2 Method of preparing 2-deoxyribose 5-phosphate
11/26/2003EP1364039A1 Process for the preparation of perillyl alcohol
11/26/2003EP1364030A2 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
11/26/2003EP1364005A2 A method for evolving a cell having desired phenotype and envolved cells
11/26/2003EP1363924A1 Avilamycin derivatives
11/26/2003EP1107723B1 A carotenoid composition containing phytoene and phytofluene
11/26/2003EP0647280B1 Over-expression of single-stranded dna molecules
11/26/2003EP0635054B1 Mammalian melanocyte stimulating hormone receptors and uses
11/26/2003EP0590058B1 HUMANIZED Heregulin ANTIBODy
11/26/2003CN1128882C Fermentation method for prepn. of D-pantothenic acid using strain of enterobacteriaceac
11/26/2003CN1128875C Method for preparing polypeptide variants
11/26/2003CN1128873C Recombinant yeasts for effective fermentation of glucose and xylose
11/25/2003USRE38331 Cells with altered betaine catabolism and their use in producing metabolites or enzymes
11/25/2003US6653533 Vectors comprising foreign nucleotide sequence; transcription factors that enhance activation of defense mechanisms
11/25/2003US6653446 Nucleotide sequences which code enzymatic polypeptide for use in treatment of gout, kidney, blood and preferential genetic disorders
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653125 Synthetic hepatitis C genes
11/25/2003US6653115 D-sorbitol dehydrogenase gene
11/25/2003US6653112 Immobilized microorganism converts crotonobetaine as such, or its salts or derivatives, into L-carnitine in a continuously operating cell reactor, and ceramics, glass heads, polyurethane disk sare used as supports
11/25/2003US6653111 Containing a recombinant plasmid pVIC40 and deposited on Nov. 19, 1987 in the collection of microorganism cultures at the USSR Antibiotics Rearch Institute under Reg. No. 1867; efficiency; nutrients; feeds; drugs
11/25/2003US6653110 Generation of glutamic acid by fermentation; obtain microorganism, incubate in nutrient broths, recover glutamic acid
11/25/2003US6653101 Transforming a eukaryotic host by transfection with transcription units containing genes encoding a transactivator; promoters; use for increasing amount of protein expressed
11/25/2003CA2100860C A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins
11/25/2003CA2083837C Recombinant dna coding for a novel protein having .beta.-1,3 glucanase activity, bacteria containing this dna, transformed plant cells and plants
11/25/2003CA1341448C Vector comprising a sequence coding for an aminoacid sequence found in a mammalian protein with g-protein-ligand membrane receptor activity
11/20/2003WO2003095659A1 Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch
11/20/2003WO2003094639A1 Microorganism reducing the amount of nitrosamine and method of reducing the amount of nitrosamine using the microorganism
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003US20030216559 Medical diagnosis using polypeptide; amplification, determination, calibration; monitoring immunotherapy
11/20/2003US20030216317 Protein having cell-recognizing activity and/or cytocidal activity
11/20/2003US20030215925 Topoisomerase-based reagents and methods for molecular cloning
11/20/2003US20030215887 Methods of testing for agonists and antagonists of cell surface receptors
11/20/2003US20030215823 Uses of galanin GALR2 receptors
11/20/2003US20030215802 Simultaneous detection,identification and differentiation of eubacterial taxa using a hybridization assay
11/20/2003US20030215792 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least on neuropeptide
11/20/2003US20030215467 Isolated from resected and washed human gastrointestinal tract; for oral administration; probiotics
11/20/2003US20030215466 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
11/20/2003US20030215461 Immunogenic composition comprising adenyl cyclase-hemolysin protein, or portion thereof, strain of Bordetella chosen from B.pertussis, B.parapertussis or B.bronchiseptica, bacterial extract containing expression product of bordetella vrg genes
11/20/2003US20030215444 And stimulate erythropoiesis; teatment of anemia
11/20/2003US20030215429 Lyophilised or sonicated Lactobacillus bacteria, grampositivie bacteria, gramnegative bacteria; antitumor agents, therapeutic treatment of autoimmune diseases, gastrointestinal disorders, nervodegenerative diseases
11/19/2003EP1362868A2 Humanized and chimeric monoclonal antibodies that bind epidermal growth factor receptor (EGF-R)
11/19/2003EP1362118A2 Method for producing d-pantothenic acid and/or salts thereof as an additive for animal feed
11/19/2003EP1362117A2 Method for producing d-pantothenic acid and/or the salt thereof as an additive for other metallic surface (2) are provided.animal food
11/19/2003EP1362116A2 Method for producing d-pantothenic acid and/or salts thereof as an additive for animal feed
11/19/2003EP1362104A2 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/19/2003EP1361794A2 Pro-apoptotic bacterial vaccines to enhance cellular immune responses
11/19/2003EP0966540B1 Mass production of paclitaxel by changing the temperature of the medium during the plant cell culture
11/19/2003EP0888434B1 Enzymatic detergent composition and method for degrading and removing bacterial cellulose
11/19/2003EP0884052B1 Cartilage/bone inducing materials for reparation
11/19/2003EP0760859B1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines
11/19/2003EP0724634B1 Method of marking eukaryotic cells by the use of a cell surface receptor as a marker
11/19/2003EP0665890B1 Increased production of secreted proteins by recombinant eukaryotic cells
11/19/2003CN1457365A Method for L-threonine production
11/19/2003CN1128224C Process for production of lipstation and tetraphydrolipstatin
11/19/2003CN1128221C Gene encoding alkaline liquefying alpha-amylase
11/18/2003US6649814 Cytochrome P450 monooxygenases
11/18/2003US6649407 Viral fiber protein for use in the treatment of viral diseases
11/18/2003US6649398 Composition for use in the propagation of bacteria
11/18/2003US6649387 Enzymatic oxidative deamination process
11/18/2003US6649382 Methods of making polyhydroxyalkanoate using biosynthesis genes from alcaligenes latus
11/18/2003US6649381 Biosynthesis of high purity polylactones
11/18/2003US6649380 Method for controlling molecular weight of polyhydroxyalkanote constituted on units containing residue of pheynyl-, thienyl-, or cyclohexyl-structure in side chain of molecule
11/18/2003US6649375 Adenoviral vectors for enhanced gene expression
11/18/2003US6649374 Recombinant Chlamydia trachomatis PGP3 antigen
11/18/2003US6649370 Isolated polynucleotide which induces a immune response when administered to a mammal; expression vectors; vaccines
11/18/2003US6649340 Protein which contains a predetermined amino acid in the hypervariable region of the antigen-binding site; use in studying structure/ function and in developing new enzymes and antibodies
11/18/2003US6649169 Cold-adapted equine influenza viruses
11/18/2003CA2143845C Self-assembling recombinant papillomavirus capsid proteins
11/18/2003CA2129239C Composition and method for protecting plants from phytopathogenic fungi